socalTECH

AUGUST 19, 2010

San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Complete Genomics is developing a DNA sequencing product which competes against products from Illumina.

Enterprise Partners 154

Enterprise Partners Patents San Diego Venture Capital 154

socalTECH

SEPTEMBER 29, 2010

Vista-based Opthonix , a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M Opthonix is venture backed by Cross Creek Capital, DAG Ventures, Enterprise Partners, Gund Investment Corp., Details on the funding have not been announced by the company.

Enterprise Partners 145

Enterprise Partners Guide Venture Capital Capital 145

socalTECH

FEBRUARY 17, 2010

San Diego-based ecoATM , a developer of automated kiosks for recycling cell phones and other electronics, said this morning that it has raised a first institutional round of funding. The round came from TAO Venture Partners, the new venture firm run by Tom Clancy. Clancy was previously managing director at Enterprise Partners.

Funding 145

Funding Enterprise Partners San Diego Capital 145

socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. The firm was advised by Peter J. Solomon Company in the deal.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140

socalTECH

JULY 30, 2014

San Diego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. GTCR said the investment came from its $3.85 XIFIN''s backers include Boulder Ventures, Enterprise Partners, and Windward Ventures. READ MORE>>.

Windward 138

Windward SaaS Enterprise Partners Equity 138

socalTECH

FEBRUARY 16, 2012

La Jolla-based Celladon Corporation , a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. Celladon is developing a compound for treating heart failure.

Enterprise Partners 124

Enterprise Partners Venture Capital Capital Invest 124

socalTECH

OCTOBER 1, 2009

The information--gleaned from funding announcements, regulatory filings, and other sources--are not far off from socalTECH's totals from last quarter, which totaled up around $932M in investment activity. San Diego led investment activity in Q3, with a large number of the biggest VC deals all located in the area.

Southern California 140

Southern California Venture Capital Northridge Tech Coast Angels 140